FDA halts COVID-19 blood plasma emergency approval Fitbit posts early findings showing its trackers can identify cases of COVID-19 before symptoms take hold How COVID-19 is shaking up medical education—for good Roche, Regeneron join forces to more than triple manufacturing of COVID-19 antibody cocktail Biopharma roundup: FitBit catches cases early in COVID study; Qiagen launches tools to map viral mutation Healthcare roundup: Top medical associations issue renewed call for public to 'Wear a Mask' Banner Health generates $4.7B in the first half of the year as it combats volume declines due to COVID-19 With AstraZeneca coronavirus vaccine deal in the bag, Australia looks to CSL for production help WuXi AppTec sees growth for CRO, clinical work, but COVID-19 still causing disruption Large employers embrace on-site clinics despite challenges posed by COVID-19: survey Qiagen launches new tools for tracking coronavirus mutations and strains Featured Story | By Ben Adams As the FDA was prepping to allow emergency use of blood plasma donation from recovered COVID-19 patients, government officials have put pay to that. read more |
| |
|---|
|
Top Stories By Conor Hale The company said its devices have been able to detect nearly half of COVID-19 cases at least one day before the participant reported any fever, cough or pain. read more By Paige Minemyer COVID-19 shows no signs of letting up soon. So medical schools are adapting their plans for education in the fall to meet the demands of the pandemic. read more By Kyle Blankenship Despite hundreds of potential COVID-19 therapies looking to make their case, very few have crossed the finish line. One promising candidate, Regeneron's two-antibody cocktail, has earned early plaudits—and now a pharma giant is jumping aboard to help boost manufacturing. read more By Eric Sagonowsky, Angus Liu, Kyle Blankenship, Conor Hale, Fraiser Kansteiner FitBit unveiled early data on its activity trackers' ability to detect COVID-19 before symptoms manifest. Qiagen rolled out new tools to help researchers track viral mutations. The Center for Health Security at Johns Hopkins unveiled an ethical vaccine distribution scheme. Plus, hospitals spent less on COVID patients in July, but costs may rise again with remdesivir purchases. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more By Robert King Banner Health generated $4.7 billion in the first half of 2020 as the hospital system fights to blunt declining patient volumes due to COVID-19. read more By Fraiser Kansteiner With an AstraZeneca vaccine deal confirmed and negotiations ongoing with other shot-makers, the Australian government is looking to domestic manufacturer CSL to churn out supplies. CSL has already partnered with the University of Queensland on its own vaccine hopeful and snared a deal with CEPI to further that work. read more By Ben Adams China-based life science giant WuXi AppTec has seen its contract research unit tick up, but it's still being hit by pandemic challenges. read more By Paige Minemyer Employer on-site clinics have proved nimble in the face of COVID-19—so expect their appeal to continue to grow, a new survey shows. read more By Conor Hale Qiagen launched new tools to capture and track emerging mutations in the novel coronavirus, which can lead to new strains that may change how the world responds to the COVID-19 pandemic. read more |
